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OBJECTIVES We sought to compare the arrhythmic risk and sensitivity to sympathetic stimulation of
mutations located in transmembrane regions and C-terminal regions of the KCNQ1 channel
in the LQT1 form of congenital long QT syndrome (LQTS).
BACKGROUND The LQT1 syndrome is frequently manifested with variable expressivity and incomplete
penetrance and is much more sensitive to sympathetic stimulation than the other forms.
METHODS Sixty-six LQT1 patients (27 families) with a total of 19 transmembrane mutations and 29
patients (10 families) with 8 C-terminal mutations were enrolled from five Japanese institutes.
RESULTS Patients with transmembrane mutations were more frequently affected based on electrocar-
diographic (ECG) diagnostic criteria (82% vs. 24%, p  0.0001) and had more frequent
LQTS-related cardiac events (all cardiac events: 55% vs. 21%, p  0.002; syncope: 55% vs.
21%, p  0.002; aborted cardiac arrest or unexpected sudden cardiac death: 15% vs. 0%, p 
0.03) than those with C-terminal mutations. Patients with transmembrane mutations had a
greater risk of first cardiac events occurring at an earlier age, with a hazard ratio of 3.4 (p 
0.006) and with an 8% increase in risk per 10-ms increase in corrected Q-Tend. The baseline
ECG parameters, including Q-Tend, Q-Tpeak, and Tpeak-end intervals, were significantly
greater in patients with transmembrane mutations than in those with C-terminal mutations
(p  0.005). Moreover, the corrected Q-Tend and Tpeak-end were more prominently
increased with exercise in patients with transmembrane mutations (p  0.005).
CONCLUSIONS In this multicenter Japanese population, LQT1 patients with transmembrane mutations are
at higher risk of congenital LQTS-related cardiac events and have greater sensitivity to
sympathetic stimulation, as compared with patients with C-terminal mutations. (J Am Coll
Cardiol 2004;44:117–25) © 2004 by the American College of Cardiology Foundationm
(
a
i
m
t
1
i
a
(
s
s
L
e
m
f
i
w
L
gongenital long QT syndrome (LQTS) is a hereditary
isorder characterized by a prolonged QT interval on the
lectrocardiogram (ECG), commonly associated with poly-
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TdP), often leading to severe symptoms, such as syncope
nd sudden cardiac death (1,2). Genetic studies have so far
dentified seven forms of congenital LQTS caused by
utations in genes of the potassium and sodium channels or
he membrane adapter located on chromosomes 3, 4, 7, 11,
7, and 21 (3–5). Among the seven forms, LQT1 syndrome
s one of the two most common genetic variants of LQTS
nd accounts for approximately 25% of genotyped patients
6). Mutations in KCNQ1 are responsible for defects in the
lowly activating component of the delayed rectifier potas-
ium current (IKs) underlying LQT1 syndrome (7). The
QT1 syndrome is frequently manifested with variable
xpressivity and incomplete penetrance (8–10) and is much
ore sensitive to sympathetic stimulation than the other
orms (11,12).
Examination of the genotype-phenotype correlation is
mportant for the management and treatment of patients
ith congenital LQTS, especially in the LQT1, LQT2, and
QT3 forms, which constitute approximately two-thirds of
enotyped LQTS (13). More recently, mutation site-
pecific differences in the severity of phenotype have been
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Mutation Site-Specific Differences in LQT1 Syndrome July 7, 2004:117–25valuated in each genotype. Moss et al. (14) have suggested
hat LQT2 patients with mutations in the pore region of
he KCNH2 gene were at markedly increased risk of
rrhythmia-related cardiac events, as compared with pa-
ients with non-pore mutations, in the International
ong-QT Syndrome Registry. With regard to the LQT1
yndrome, Donger et al. (15) initially suggested that the
issense mutation, R555C, located in the C-terminal
egion of the KCNQ1 gene was associated with a less severe
henotype than the mutations in the transmembrane re-
ions. Since then, more than 20 mutations located in the
-terminal region of the KCNQ1 gene have been reported,
ut neither the severity nor the function of the mutations
as been fully determined. In the present study, we com-
ared the arrhythmic risk and sensitivity to sympathetic
timulation with exercise between LQT1 patients with
utations located in the transmembrane regions and those
ith mutations in the C-terminal regions of the KCNQ1
ene.
ETHODS
atient population. The study population consisted of 95
atients from 37 unrelated Japanese LQT1 families enrolled
rom five institutes in Japan: the National Cardiovascular
enter, Kyoto University Graduate School of Medicine,
anazawa University, Niigata University Graduate School
f Medical and Dental Science, and Okayama University
raduate School of Medicine and Dentistry. The KCNQ1
utations were confirmed in all patients by using standard
enetic tests. Briefly, genomic deoxyribonucleic acid (DNA)
as isolated from leukocyte nuclei by conventional methods.
creening for mutations of KCNQ1, KCNH2, SCN5A,
CNE1, and KCNE2 was performed by using polymerase
hain reaction (PCR)/single-strand conformation polymor-
hism or denatured high-performance liquid chromatogra-
hy analyses. For aberrant PCR products, DNA sequencing
as conducted with a DNA sequencer (3700 DNA Ana-
yzer, PE Applied Biosystems, Foster City, California). If
he patients had double mutations within the KCNQ1 gene
r accompanying additional mutations in other genes, they
Abbreviations and Acronyms
APD  action potential duration
DNA  deoxyribonucleic acid
ICl(Ca)  Ca
2-activated chloride current
IKr  fast component of the delayed rectifier
potassium current
IKs  slow component of the delayed rectifier
potassium current
INa-Ca  Na
/Ca2 exchange current
LQTS  long QT syndrome
LZ  leucine zipper
PCR  polymerase chain reaction
TdP  torsade de pointes
Tpeak-end  interval between Tpeak and Tendere excluded from the present study. Genotyping of pQTS was reviewed and approved according to each Insti-
utional Review Board’s guideline, and written, informed
onsent was obtained from all patients. No patients were
aking beta-blockers at the time of the baseline ECG and
xercise treadmill test.
linical characterization. Routine clinical and ECG pa-
ameters were usually obtained at the time of first admission
o each institute for evaluation of LQTS, and thereafter at
he time of at least yearly follow-up contact.
LINICAL DIAGNOSIS. We evaluated two major clinical
CG criteria for diagnosing LQTS-affected individuals.
he ECG diagnostic criteria of Keating et al. (16), included
corrected QT (QTc) interval 470 ms in asymptomatic
ndividuals and a QTc interval 440 ms for males and
460 ms for females, were associated with one or more of
he following: 1) stress-related syncope; 2) documented
dP; or 3) a family history of early sudden cardiac death.
he LQTS was also diagnosed by the diagnostic criteria
score 4) of Schwartz et al. (17).
ASELINE 12-LEAD ECG MEASUREMENTS. Baseline 12-lead
CG parameters included the RR, Q-Tend, Q-Tpeak, and
peak-end (Q-Tend  Q-Tpeak) intervals as an index of
ransmural dispersion of repolarization. The Q-Tend,
-Tpeak, and Tpeak-end intervals were also corrected
sing Bazett’s method. These parameters were measured
anually in three leads (II, V2, and V5), with quantitative
epolarization values reported for lead V5, because the
easurements were similar in all three leads. Q-Tend was
efined as the interval between the QRS onset and the point
t which an isoelectric line intersected a tangential line
rawn at the minimum first derivative (dV/dt) point of the
ositive T-wave or at the maximum dV/dt point of the
egative T-wave. When a bifurcated or secondary T wave
using the first component appeared, it was included as part
f the measurement of Q-Tend, but a normal U-wave,
hich was apparently separated from a T-wave, was not
ncluded. Q-Tpeak was defined as the interval between the
RS onset and the peak of the positive T-wave or the nadir
f the negative T-wave. Measurements were carried out by
wo investigators who were unaware of the subjects’ genetic
tatus. There were no significant differences in the measured
ata between the two (data not shown). In addition, TdP
nd T-wave alternans on the ECG were assessed.
ARDIAC EVENTS, THERAPY, AND FOLLOW-UP. Congenital
QTS-related cardiac events were defined as syncope,
borted cardiac arrest, or unexpected sudden cardiac death
ithout a known cause. Cardiac events, which brought the
robands to medical attention but were secondary to appar-
nt causes known to prolong repolarization, such as anti-
rrhythmic drugs, electrolyte abnormalities, or bradycardia,
ere excluded from the analysis of congenital LQTS-
elated cardiac events. Such secondary cardiac events were
ocumented in one patient with C-terminal mutation (hy-
okalemia 1) and one patient with transmembrane mutation
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July 7, 2004:117–25 Mutation Site-Specific Differences in LQT1 Syndromehypokalemia 1). Therapy, including beta-blockers, pace-
akers, sympathectomy, and defibrillator, was also evalu-
ted. Follow-up was censored at age 50 years to avoid the
nfluence of coronary artery disease on cardiac events in the
apanese population.
XERCISE TREADMILL TESTING. Forty-nine of the 95 pa-
ients were included for the analysis with exercise treadmill
esting. All patients were in sinus rhythm, and none had
trioventricular or bundle branch block during the exercise
esting. Exercise treadmill testing was performed using the
tandard Bruce protocol. Twelve-lead ECGs were recorded
very 1 min from the baseline condition through the
aximal exercise to the recovery phase for 8 min. The ECG
easurements before exercise were obtained in the standing
osition before exercise, and those after exercise were
sually obtained within 2 min after stopping exercise to
void noise in the measurement.
enetic characterization. Genetic mutations of the
CNQ1 amino acid sequence were characterized by a
pecific location and coding effect (missense, splice site,
rameshift, or deletion). The transmembrane regions were
efined as six transmembrane segments (S1 to S6, amino
cid residues 112 through 354), including cytoplasmic and
xtracellular linkers as well as the pore region. The pore
egion of the KCNQ1 channel was defined as the area
xtending from S5 to the mid-portion of S6 involving
mino acid residues 301 through 320.
tatistical analysis. Data are expressed as the mean value
SD. Repeated measures two-way analysis of variance
ANOVA), followed by the Scheffe´ test, was used to
ompare data between mutations located in the transmem-
rane regions and those in the C-terminal regions, as well as
o compare measurements made before and after exercise
STATISTICA, 1998 edition). Repeated measures one-
ay ANOVA, followed by the Scheffe´ test, was used to
ompare changes () in the measurements with exercise
etween the groups. Differences in frequencies were ana-
yzed by the chi-square test. A two-sided p value0.05 was
onsidered to indicate significance. The cumulative proba-
ility of a first cardiac event was assessed by the Kaplan-
eier method and log-rank statistic. The multivariate Cox
roportional hazards survivorship model (adjusting for mu-
ation locations, age, and gender) was used to evaluate the
ndependent contribution of clinical and genetic factors to
rst cardiac events from birth through to age 50 years.
linical data were also compared between transmembrane
utations and C-terminal mutations for the probands and
on-probands, separately. Because the non-probands (fam-
ly members) in this study were mainly relatives in the first
r second degree of the probands, the non-probands in each
amily were equally handled in the analysis.
ESULTS
enetic characteristics. Table 1 illustrates the numbers of
QT1 patients by mutation and location (18–24). We Cdentified 27 KCNQ1 mutations among the 95 LQT1
atients, with 19 mutations located in the transmembrane
egions and eight mutations in the C-terminal regions. Four
utations were located at the pore region in the transmem-
rane domain. Twenty-three of the 27 mutations were
issense mutations; 2 were frameshift mutations; 1 was a
eletion mutation; and 1 was a splice mutation. Thirteen
utations (seven in the transmembrane regions and six in
he C-terminal regions) were novel. Functional effects by
ellular electrophysiologic tests have been reported in eight
f the 27 mutations (Table 1).
linical characteristics. Sixty-six patients from 27 unre-
ated families had mutations located in the transmembrane
egions, and 29 patients from 10 unrelated families had
utations located in the C-terminal regions. Table 2
llustrates the clinical characteristics of the patient popula-
ion. No significant differences were observed with regard to
ender, percentage of proband, and age at baseline ECG
ecordings. The LQTS-affected individuals were more fre-
uently diagnosed in patients with transmembrane muta-
ions than in those with C-terminal mutations. The LQTS
iagnostic score of Schwartz et al. (17) was significantly
igher in patients with transmembrane mutations. The
-Tend, Q-Tpeak, and Tpeak-end intervals, both uncor-
ected and corrected, were significantly greater in patients
ith transmembrane mutations than in those with
-terminal mutations (Figs. 1A and 1C). Although the
requency of TdP was no different, that of T-wave alternans
as higher in patients with transmembrane mutations.
atients with transmembrane mutations had more frequent
QTS-related cardiac events (all cardiac events, syncope,
nd aborted cardiac arrest or unexpected sudden cardiac
eath) than did those with C-terminal mutations. More
herapy with beta-blockers for LQTS was initiated in
atients with transmembrane mutations.
linical course by mutation location. Figure 2A illus-
rates Kaplan-Meier cumulative cardiac event curves from
irth through to age 50 years for a total of 95 patients with
utations located in the transmembrane regions (n  66)
nd C-terminal regions (n  29). The difference in the
linical course by mutation location was significant (log-
ank, p  0.005), with a greater risk of first cardiac events
n patients with transmembrane mutations than in those
ith C-terminal mutations. Most of the first cardiac events
ccurred before age 15 years in LQT1 patients with
ransmembrane mutations, whereas half of the LQT1 pa-
ients with C-terminal mutations had their first cardiac
vents after age 15 years. Multivariate Cox proportional
azards regression analysis revealed that patients with trans-
embrane mutations had a greater risk of first cardiac
vents, with a hazard ratio of 3.4 (95% confidence interval
.4 to 8.2, p  0.006). The corrected Q-Tend modulated
he risk among patients with transmembrane mutations,
ith an 8% increase in risk per 10-ms increase in corrected
-Tend, but had no effect on risk among patients with
-terminal mutations. Figures 2B and 2C illustrate Kaplan-
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Mutation Site-Specific Differences in LQT1 Syndrome July 7, 2004:117–25eier cumulative cardiac event curves for 37 probands and
8 non-probands with transmembrane mutations and
-terminal mutations, respectively. The difference in phe-
otype severity based on mutation location persisted (p 
.007) in the non-probands. There was no significant
ifference in the clinical course of the probands according to
utation site, although the number of probands was rela-
ively small.
xercise treadmill testing. Exercise treadmill testing was
onducted in 33 patients with transmembrane mutations
nd 16 patients with C-terminal mutations. Table 3 illus-
rates the ECG measurements before and after exercise
esting in both patient groups. The baseline RR and
orrected repolarization parameters before exercise in both
roups showed quite similar values to those evaluated in the
otal patients (Table 2), indicating that these patients who
ad exercise testing were representative of each group. The
R interval was similarly shortened with exercise between
he two groups. Exercise produced a significant prolonga-
ion in the corrected Q-Tend interval, but not at all in
orrected Q-Tpeak, resulting in a significant increase in
orrected Tpeak-end in both groups. These changes were
able 1. KCNQ1 Mutations by Location, Amino-Acid Coding, T
Location and Coding
No. of
Families
No. of
Subjects Po
ransmembrane domains
Pore region
G306R 1 2 Po
I313K* 1 1 Po
G314A* 1 1 Po
G314S 1 1 Po
Non-pore region
R174H 1 2 S2
F193L 1 4 S2
A226V* 1 3 S4
R237P* 1 1 S4
R243C 2 4 S4
R243I* 1 2 S4
V254M 2 3 S4
R259C 1 1 S4
G269S 3 6 S5
S277L* 2 4 S5
G325R 1 4 S6
delF339 1 2 S6
A341V 4 19 S6
A344sp 1 4 S6
A344E* 1 2 S6
-terminus region
R451Q* 1 1 C
I517T* 1 3 C
A525V* 2 2 C
L572fs/20* 1 3 C
T587M 2 2 C
R591H 1 6 C
D611Y* 1 10 C
H637fs/28* 1 2 C
Novel mutation.
del  deletion; sp  last unaffected amino acid before predicted splice mutaion; fs
ermination); term.  terminus.uch more pronounced in patients with transmembrane putations than in those with C-terminal mutations (Figs.
B and 1D). Therefore, the increases in the corrected
-Tend and corrected Tpeak-end intervals with exercise
ere significantly greater in patients with transmembrane
utations (Table 3).
When we re-analyzed the ECG measurements for the
robands (n  26) and for the non-probands (n  23)
eparately, the corrected Q-Tend intervals both before and
fter exercise were longer in the probands than in the
on-probands. However, the magnitude of differences in
orrected Q-Tend for the two mutation groups persisted
fter this re-analysis both in the probands and non-
robands (data not shown).
ISCUSSION
he major findings of the present study are: 1) LQT1
atients with mutations located in the transmembrane
egions are at a higher risk of congenital LQTS-related
ardiac events than are patients with C-terminal mutations;
nd 2) LQT1 patients with transmembrane mutations had
greater sensitivity to sympathetic stimulation than did
of Mutation, and Reported Functional Effects
Exon Type
Functional Effect in
Expression Studies
6 Missense Dominant negative (18)
7 Missense
7 Missense
7 Missense Dominant negative (19,20)
2 Missense
3 Missense Loss of function (21)
4 Missense
5 Missense
5 Missense Loss of function (22)
5 Missense
5 Missense Dominant negative (18)
5 Missense Loss of function (23)
6 Missense
6 Missense
7 Missense
7 Deletion
7 Missense Loss of function (18)
7 Splice site
7 Missense
. 10 Missense
. 12 Missense
. 12 Missense
. 14 Frameshift
. 15 Missense Trafficking abnormality (24)
. 15 Missense
. 16 Missense
. 16 Frameshift
amino acid affected by a frameshift (number after fs is number of amino acids beforeype
sition
re
re
re
re
/S3
/S3
/S5
/S5
/S5
/S5
/S5
-term
-term
-term
-term
-term
-term
-term
-term
 firstatients with C-terminal mutations.
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July 7, 2004:117–25 Mutation Site-Specific Differences in LQT1 Syndromeutation site-specific arrhythmic risk in LQT1 syn-
rome. Moss et al. (14) have recently reported that the
reater risk of arrhythmia-related cardiac events in LQT2
atients with pore mutations of the KCNH2 gene was
onsistent with the cellular electrophysiologic effects of the
CNH2 mutations, with pore mutations showing a greater
egative effect on the rapidly activating component of the
elayed rectifier potassium current (IKr) than non-pore
utations. Although the cellular electrophysiologic effects
f a small percentage of known KCNQ1 mutations have
een reported to be like those of KCNH2 mutations, several
n vitro electrophysiologic studies have reported missense
utations with dominant-negative effects on IKs in the
ransmembrane regions of the KCNQ1 gene (18,19,25,26).
owever, Wang et al. (18) have suggested that the degree of
Ks suppression by KCNQ1 transmembrane mutations eval-
ated in the heterologous expression system did not corre-
ate with severity in the clinical phenotype in LQT1
atients. There have been fewer reports on the cellular
lectrophysiologic effects of the C-terminal mutations of the
CNQ1 gene. To the best of our knowledge, the electro-
hysiologic effects were examined in seven C-terminal
utations of the KCNQ1 gene (R555C, R533W, R539W,
544, G589D, T587M, and G643S) by French, Finland,
nd Japanese groups (19,20,24,27–30). All seven
Table 2. Clinical Characteristics of the Study P
Transm
Demographics
Female gender (%)
Proband (%)
Age (yrs) at ECG (range) 3
Diagnosis
Diagnosed LQTS (Keating)
Diagnosed LQTS (Schwartz 4)
Schwartz score
Baseline ECG measurements
RR (ms)
Q-Tend (ms)
Q-Tpeak (ms)
Tpeak-end (ms)
Corrected Q-Tend (ms)
Corrected Q-Tpeak (ms)
Corrected Tpeak-end (ms)
Torsade de pointes (%)
T-wave alternans (%)
Cardiac events
All cardiac events (%)
Age (yrs) at first events (range) 1
Syncope (%)
Aborted cardiac arrest/SCD (%)
Therapy
Beta-blockers (%)
Pacemakers (%)
Sympathectomy (%)
Defibrillator (%)
Data are presented as the mean value  SD or number (%)
ECG  electrocardiography; LQTS  long QT syndrom-terminal mutations, except for 544 and T587M, when eo-expressed with KCNE1, could produce functional het-
romultimeric channels and showed only a mild reduction
f IKs due to a rightward voltage shift in the activation
rocess and/or acceleration of the deactivation kinetics.
eyroud et al. (28) have reported a homozygous deletion-
nsertion mutation in the C-terminal region of the KCNQ1
ene (544), causing a severe phenotype—the Jervell and
ange-Nielsen syndrome. However, the heterozygotes of
544 clinically displayed mild or no QT prolongation, with
o symptoms, mainly due to the lower dominant-negative
ffects of the 544 mutant. More recently, Larsen et al. (31)
ave described a severe form of Romano-Ward syndrome
ssociated with compound heterozygosity for two
-terminal mutations (R518X and A525T) in the KCNQ1
ene. Once again, none of the heterozygotes of the
-terminal mutations (R518X or A525T) had symptoms
ith minor or no QT prolongation. These previous reports
n C-terminal mutations in the KCNQ1 gene indicate a less
evere phenotype in C-terminal mutations than that in
ransmembrane mutations in LQT1 syndrome, concordant
ith the findings in the present study.
It is noteworthy that most of the first cardiac events
ccurred before age 15 years in the LQT1 patients with
ransmembrane mutations, whereas half of the LQT1 pa-
ients with C-terminal mutations had their first cardiac
lation
rane Domain
66)
C-Terminal
(n  29) p Value
62%) 14 (48%) NS
44%) 8 (28%) NS
0 (6–83) 28  17 (4–64) NS
82%) 7 (24%)  0.0001
65%) 5 (17%)  0.0001
 2.1 2.0  1.5  0.0001
 127 918  131 NS
 54 419  46  0.0001
 46 349  44 0.002
 20 71  12  0.0001
 46 439  38  0.0001
 42 365  39 0.0002
 19 74  11  0.0001
15%) 2 (7%) NS
15%) 0 0.03
55%) 6 (21%) 0.002
(3–48) 13  9 (2–25) NS
55%) 6 (21%) 0.002
15%) 0 0.03
45%) 6 (21%) 0.02
2%) 0 NS
0 0 NS
0 0 NS
jects.
D  sudden cardiac death.opu
emb
(n 
41 (
29 (
2  2
54 (
43 (
4.4
910
472
382
90
496
402
95
10 (
10 (
36 (
1  8
36 (
10 (
30 (
1 (
of subvents after age 15 years. This tendency holds up regardless
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Mutation Site-Specific Differences in LQT1 Syndrome July 7, 2004:117–25f whether the patient was a proband. Moreover, hypoka-
emia, which is known to prolong repolarization, unmasked
he LQTS proband in a patient with C-terminal mutation
n the present study. These findings suggest that careful
igure 1. Electrocardiographic parameters in lead V5 before and after ex
A341V, non-proband, 16-year-old male) (A and B) and in the C-termin
orrected Q-Tend (cQ-Tend), Q-Tpeak (cQ-Tpeak), and Tpeak-end (cT
han in the patient with a C-terminal mutation (A and C). Exercise produ
ith a transmembrane mutation than in the patient with a C-terminal m
igure 2. (A) Kaplan-Meier cumulative cardiac event curves from birth th
n the transmembrane regions (n 66) and C-terminal regions (n 29). T
 0.005), with a greater risk of first cardiac events in patients with transumulative cardiac event curves for 37 probands (B) and 58 non-probands (C)ollow-up is needed in LQT1 patients with C-terminal
utations, despite their less severe phenotype, by limiting
xposure of these patients to QT prolonging conditions.
Although the difference in the clinical course based on
in LQT1 patients with mutations located in the transmembrane region
gion (D611Y, non-proband, 16-year-old male) (C and D). The baseline
end) intervals were greater in the patient with a transmembrane mutation
ore prominent increases in the cQ-Tend and cTpeak-end in the patient
n (B and D).
to age 50 years for a total of 95 patients with KCNQ1 mutations located
erence in the clinical course by mutation location was significant (log-rank,
brane mutations than in those with C-terminal mutations. Kaplan-Meierercise
al re
peak-
ced mrough
he diff
memwith transmembrane mutations and C-terminal mutations.
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July 7, 2004:117–25 Mutation Site-Specific Differences in LQT1 Syndromeutation location was obvious in the non-probands, no
ignificant difference was observed in the clinical course
ccording to mutation location in the probands. This is not
urprising, because probands are usually brought to medical
ttention by their first cardiac events, especially those with a
ess prolonged QT interval. There indeed may be no
ifference in cardiac events based on mutation location for
robands. This is because other modifier genes may be
ontributing to the more severe phenotype, which leads to
he individual receiving a label of “proband.”
Zareba et al. (32) recently reported on 294 LQT1
atients in the International Long-QT Syndrome Registry
nd analyzed the QTc interval and cardiac event rates by
utation location. In contrast to the present study, they
ound no significant differences in QTc or risk of cardiac
vents when the patients were separated into those with
ransmembrane mutations and those with C-terminal mu-
ations. However, only six transmembrane mutations were
verlapped between the two studies (out of 31 transmem-
rane mutations in the Registry and 19 transmembrane
utations in this study). Moreover, no overlap was observed
n the C-terminal mutations between the two studies (out of
1 C-terminal mutations in the Registry and 8 C-terminal
utations in this study). In transmembrane regions, the S4
o S5 loop (amino acid residues 221 through 300) and the
6 segment (amino acid residues 325 through 354) are
nown to be important for voltage-dependent IKs function
22); thus, a more severe phenotype is expected in mutations
ocated in the S4 to S5 loop and the S6 segment than in the
2 to S3 loop (amino acid residues 148 through 220). The
ransmembrane mutations in the non-pore region in the
resent study were located in the S4 to S5 loop and the S6
Table 3. Electrocardiographic Measurements B
T
Demographics
Female gender (%)
Proband (%)
Age (yrs) at ECG (range)
ECG measurements before exercise
RR (ms)
Corrected Q-Tend (ms)
Corrected Q-Tpeak (ms)
Corrected Tpeak-end (ms)
ECG measurements after exercise
RR (ms)
Corrected Q-Tend (ms)
Corrected Q-Tpeak (ms)
Corrected Tpeak-end (ms)
Changes in ECG measurements with exercise
RR (ms)
Corrected Q-Tend (ms)
Corrected Q-Tpeak (ms)
Corrected Tpeak-end (ms)
*p  0.005 vs. before exercise. Data are presented as the mea
(ECG) measurements after exercise were obtained within 2egment, except for two mutations found in the S2 to S3 ioop. This may affect the result that cardiac event rates were
igher in patients with transmembrane mutations in the
resent study than those in the Registry. Interestingly, when
he patients with transmembrane mutations in the present
tudy were separated into those with pre-pore mutations
nd those with pore mutations, according to the definition
y Zareba et al. (32), the patients with pore mutations had
longer corrected Q-Tend than did those with pre-pore
utations (data not shown). Overall, our data present
vidence that mutation site-specific differences in arrhyth-
ic risk exist, in contrast to findings previously reported
rom the Long-QT Syndrome Registry. Therefore, a larger
atient population per mutation and a greater spectrum of
CNQ1 mutations by corroboration with other investiga-
ors are clearly needed to make a definitive conclusion about
he mutation site-specific differences in arrhythmic risk in
QT1 syndrome.
reater sensitivity to sympathetic stimulation in trans-
embrane mutations of the KCNQ1 gene. The LQT1
yndrome is reported both clinically and experimentally to
e the most sensitive to sympathetic stimulation among the
even forms of LQTS (9–12). Sympathetic stimulation is
nown to increase the net outward repolarizing current due
o a larger increase in outward currents, including Ca2-
ctivated IKs and Ca
2-activated chloride current (ICl(Ca)),
ompared with the inward Na/Ca2 exchange current
INa-Ca), resulting in an abbreviation of action potential
uration (APD) and QT interval under normal conditions.
defect in IKs in LQT1 syndrome could account for the
ailure of sympathetic stimulation to abbreviate the QT
nterval and APD, especially in the mid-myocardial regions,
esulting in a paradoxical QT prolongation and an increase
and After Exercise Testing
embrane Domain
(n  33)
C-Terminal
(n  16) p Value
18 (55%) 7 (44%) NS
22 (67%) 4 (25%) 0.006
 16 (9–72) 27  13 (6–45) NS
862  128 850  106 NS
494  40 435  28 0.0001
403  37 359  26 0.0001
91  12 76  6 NS
514  87* 503  74* NS
571  45* 470  39* 0.0001
420  38 365  51 0.0001
151  34* 106  17* 0.0001
349  119 348  137 NS
77  32 35  17 0.0001
17  36 5  30 NS
60  34 30  17 0.002
D value or number (%) of subjects. The electrocardiographic
fter stopping exercise.efore
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lation (12). In fact, recent clinical studies have demon-
trated that sympathetic stimulation with epinephrine infu-
ion or exercise produced a more significant increase in
-Tend and Tpeak-end intervals in LQT1 compared with
QT2 patients (33–35). More recently, the Q-Tend and
peak-end intervals both before and after epinephrine and
rolongation of Q-Tend with epinephrine were reported to
e greater in symptomatic than asymptomatic patients with
QT1 syndrome (9). In the present study, LQT1 patients
ith transmembrane mutations, who had more frequent
QTS-related cardiac events than those with C-terminal
utations, showed greater baseline Q-Tend and Tpeak-end
ntervals and a greater increase in both Q-Tend and
peak-end intervals with exercise than those with
-terminal mutations. The data in the present study may
ndicate a stricter exercise limit and a more aggressive use of
eta-blockers in LQT1 patients with transmembrane mu-
ations, but once again, we need to evaluate a larger patient
opulation to make a definitive recommendation.
With regard to the sympathetic regulation of IKs, Marx
t al. (36) have suggested that beta-adrenergic modulation
f IKs required targeting of cyclic adenosine monophos-
hate (cAMP)-dependent protein kinase and protein
hosphatase-1 to KCNQ1 through the targeting protein
otiao. The binding of protein kinase and protein
hosphatase-1 to the KCNQ1 channel through yotiao is
ediated by leucine zipper (LZ) motifs located in the
-terminal of the KCNQ1 gene (amino acid residues 588 to
16). They also reported that the G589D mutant channel
ocated in the LZ motifs of the C-terminus prevented
AMP-dependent regulation of IKs, and thus may not
espond to beta-adrenergic stimulation, resulting in a defect
f APD shortening and further prolonging of the APD.
he G589D mutation was not included among the
-terminal mutations of the present study. Two C-terminal
utations, R591H and D611Y, located in the LZ motifs
ere included in the present study. However, the prolon-
ation of the QTc interval was mild in patients with the two
utations (Fig. 1). Further clinical evaluation will be
equired to conclude the role of LZ motifs in the
-terminus on sympathetic modulation of the IKs channel.
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